Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.43 |
| ▸ | SYK | P43405 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.42 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | PIM1 | P11309 | 1/20 | 0.38 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9259584 | 0.94 | LTB4R (0.43) | PRMT6SYKCYP2A6CYP2E1CYP2B6 | |
| SCHEMBL14642800 | 0.92 | TAAR1 (0.46) | PRMT6SYKCYP2A6CYP2E1CYP2B6 | |
| SCHEMBL5194919 | 0.89 | CYP2A6 (0.57) | SYKCYP2A6CYP2B6KDRPDGFRB | |
| SCHEMBL9251002 | 0.87 | SLC9A3 (0.41) | PRMT6SYKCYP2A6CYP2E1CYP2B6 | |
| SCHEMBL9257607 | 0.84 | ALDH1A1 (0.47) | PRMT6CYP2A6CYP2E1CYP2B6KDR | |
| SCHEMBL9166872 | 0.82 | LTB4R (0.43) | PRMT6CYP2A6CYP2E1CYP2B6KDR | |
| SCHEMBL9249970 | 0.82 | LTB4R (0.43) | PRMT6CYP2A6CYP2E1CYP2B6KDR | |
| SCHEMBL9254689 | 0.81 | PRMT6 (0.40) | PRMT6CYP2A6CYP2E1CYP2B6KDR | |
| SCHEMBL10682119 | 0.80 | LTA4H (0.55) | LTA4H | |
| SCHEMBL9259837 | 0.80 | PRMT6 (0.40) | PRMT6CYP2A6CYP2E1CYP2B6KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080318878-A1 | Antibacterial Agents | RANBAXY LABORATRIES LIMITED (IN) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318878-A1 | Antibacterial Agents | MLX, MGAM, CAT | PRMT6 4657/4885SYK 4385/4885CYP2A6 1079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.